Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillance
The study investigated how stem-like tumor-specific CD8+ T cells in tumor-draining lymph nodes are maintained over time, focusing on the movement of tumor-experienced T cells. Using photoconversion fate-mapping of intratumoral T cells, the authors found that effector cells exit the tumor microenvironment, migrate to the draining lymph node, avoid chronic antigen stimulation, re-express TCF1, and enter a stem-like state; they report that dendritic cell antigen presentation in lymph nodes drives proliferation that enlarges the stem-like population. A stated caveat is that the work centers on tumor models and links maintenance of stem-like T cells and immune checkpoint blockade response to constitutive lymphatic transport and to the impact of lymph node metastasis on the stem-like niche, which may limit generalization beyond those settings. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,192 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00